DEKA REVOLUTION FOR ADVANCED WOUND HEALING AND CARE
Chronic wound care has become a top-priority issue for health systems
worldwide. The expenditure for wound management has been rising in
last years and will experience further growth, due to progressive ageing of
population. It is estimated that about 7 million patients are affected by chronic
wounds in U.S.A. alone, where US$25 billion dollars are spent annually.
The continuous DEKA’s innovation research has revolutionized the field
of chronic wounds management thanks to SmartXide2 surgical CO2 laser.
SmartXide2 offers a great adjunctive treatment approach in wound therapy,
particularly in difficult-to-heal cutaneous wounds, allowing clinicians to achieve
unexpected results in wound closures as never before.
• Diabetic foot ulcers
• Venous leg ulcers
• Pressure ulcers
• Wound dehiscence